Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01032265
Other study ID # FAS dnr 2008-0952
Secondary ID VLL 759-2008VLL-
Status Completed
Phase N/A
First received
Last updated
Start date December 2009
Est. completion date April 2011

Study information

Verified date February 2022
Source Umeå University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether treatment of female stress urinary incontinence using a web-based programme is effective.


Description:

Female urinary incontinence is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is stress urinary incontinence (SUI), i.e leakage when coughing, sneezing or jumping. There is no association between SUI and serious medical conditions. Thus investigation can be kept to a minimum, including structured history taking and a bladder diary for correct diagnosis. Treatment with lifestyle intervention and pelvic floor muscle training (PFMT) give improvement or cure in 60-70% of women. A small study indicates that treatment with cognitive behavioural therapy (CBT) may improve incontinence-related quality of life and symptoms of urinary incontinence. Web-based management of SUI has as far as we know never been evaluated in a randomized controlled study. The aim of this study is to determine if web-based management of female SUI, with a treatment using PFMT and elements of CBT is effective compared to treatment supported by a pamphlet. The duration of the treatment programme is three months, follow-up at four months, 1 year and two years.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - stress urinary incontinence - leakage once a week or more often - ability to read and write Swedish - asset to computer with Internet connection Exclusion Criteria: - pregnancy - former incontinence surgery - known malignancy in lower abdomen - difficulties with passing urine - visual blood in urine - intermenstrual bleeding - severe psychiatric diagnosis - neurological disease with affection on sensibility in legs or lower abdomen

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Web-based treatment with PFMT and elements of CBT
125 women with stress urinary incontinence(SUI) participate in web-based treatment for 3 months. Treatment consists of information, PFMT and uses elements of CBT. It includes regular email contact with urotherapist.
Pamphlet treatment
125 women with SUI receive a pamphlet with information and a programme for PFMT.

Locations

Country Name City State
Sweden Umea University Umeå

Sponsors (4)

Lead Sponsor Collaborator
Umeå University Jämtland County Council, Sweden, Swedish Council for Working Life and Social Research, Västernorrland County Council, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) summed symptom-score, range 0-21, with higher scores indicating greater severity. baseline, 4 months
Primary International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) condition-specific quality of life, summed score, range 19-76, higher scores indicate greater impact on quality of life. baseline, 4 months
Secondary EuroQol Five Dimensions Visual Analogue Scale (EQ5D-VAS) health-specific quality of life, range 0-100, higher scores indicate better quality of life. baseline, 4 months
Secondary Usage of Incontinence Aids Only those using incontinence aids at baseline were included in the analysis. baseline, 4 months
Secondary Patient Satisfaction 4 months
Secondary Incontinence Episode Frequency (IEF) number of incontinence episodes per week baseline, 4 months
Secondary Patient's Global Impression of Improvement Scale (PGI-I) 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT05534269 - Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy Phase 2
Completed NCT02023502 - Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study
Completed NCT01848938 - Treatment of Stress Urinary Incontinence Via Smartphone N/A
Completed NCT01699425 - Multicentric Comparative Randomized Study of the Single-incision Sling Ajust® Versus Suburethral Transobturator Slings. N/A
Completed NCT02418299 - Er:YAG Laser Treatment for Female Stress and Mixed Urinary Incontinence (IncontiLase) N/A
Completed NCT01094353 - A Comparative Study Minisling Versus Transobturator (TOT)Sling Phase 4
Completed NCT00910338 - Efficacy and Safety of Extracorporeal Biofeedback N/A
Completed NCT01290796 - Clinical Evaluation of Ajustâ„¢ in Stress Urinary Incontinence N/A
Recruiting NCT04131387 - The Safety and Efficacy of Micro-energy Ultrasound Therapy in the Treatment of Female Stress Urinary Incontinence N/A
Not yet recruiting NCT02981654 - Safety and Efficacy of Carbone Dioxide (CO2) Laser System in Treatment of Female Stress Urinary Incontinence. N/A